Glucagonoma other diagnostic studies

Glucagonoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Glucagonoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Glucagonoma other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Glucagonoma other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Glucagonoma other diagnostic studies
CDC on Glucagonoma other diagnostic studies
Glucagonoma other diagnostic studies in the news
Blogs on Glucagonoma other diagnostic studies
Directions to Hospitals Treating Glucagonoma
Risk calculators and risk factors for Glucagonoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Other Studies

• Biopsy:

• Skin biopsy is a good test for skin lesions. Pathologists may find necrolytic migratory erythema in patients with glucagonoma.

• Epidermal necrosis

• Subcorneal pustules, either isolated or associated with necrosis of the epidermis

• Confluent parakeratosis

• Epidermal hyperplasia, and marked papillary dermal angioplasia

• Suppurative folliculitis

References

Template:WikiDoc Sources